Finally, Yang, et al., demonstrated improved survival in a murine orthotopic model of disseminated ovarian cancer with treatment with a conditionally replicating adenovirus expressing TIMP2, an inhibitor of MMP9 [35]. This evidence concerns the gene MMP9 and ovarian cancer.